|
US2020103399A1
|
|
Methods for rare event detection
|
|
US2019085318A1
|
|
Solid phase negative enrichment
|
|
US2019071716A1
|
|
Bodily fluid enrichment
|
|
US2019048425A1
|
|
Tumor detection and monitoring
|
|
EP3794139A1
|
|
Sequence specific methylation enrichment and detection
|
|
US2019032116A1
|
|
Sequence specific methylation enrichment and detection
|
|
WO2019005806A1
|
|
Bodily fluid target enrichment
|
|
EP3638812A2
|
|
Rare nucleic acid detection
|
|
WO2018231985A1
|
|
Polynucleic acid molecule enrichment methodologies
|
|
WO2018231955A2
|
|
Isolation of target nucleic acids
|
|
US2018355409A1
|
|
Tumor mutation burden by quantification of mutations in nucleic acid
|
|
US2018355437A1
|
|
Plasma/serum target enrichment
|
|
CA3069831A1
|
|
Detection of targeted sequence regions
|
|
WO2018231957A1
|
|
Tumor mutation burden
|
|
CA3069934A1
|
|
Negative-positive enrichment for nucleic acid detection
|
|
US2019382824A1
|
|
Negative-positive enrichment for nucleic acid detection
|
|
US2018355408A1
|
|
Selective protection of nucleic acids
|
|
US2018355380A1
|
|
Methods and kits for quality control
|
